Skip to content
Artwork for RheumMadness Rheumatology Podcast
Education

RheumMadness Rheumatology Podcast

RheumMadness

The RheumMadness podcast is part of a rheumatology learning initiative started with the assistance of the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award. Go to https://sites.duke.edu/rheummadness/ to learn more. RheumMadness is created by David Leverenz, MD, who is the recipient of the CSE award.

  • 20 episodes
  • Updated Apr 16, 2025

Episodes20

  • Apr 16, 2025 · 9 min

    5.15 Final Results and Thank You

    In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness

  • Apr 2, 2025 · 33 min

    5.14 Round 1 Reactions

    In this episode, we breakdown our reactions to the first round of RheumMadness 2025, plus we reveal which teams the participants liked the most in their brackets. To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness

  • Mar 26, 2025 · 2 min

    5.13 Submit Those Brackets!

    Reminder to Submit your brackets by March 31, 2025 at 11:59pm ET! Link to the RheumMadness OnePager by Dr. Mithu Maheswaranathan (@MithuRheum) To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness

  • Mar 19, 2025 · 26 min

    5.12 Bracketology

    In this episode, the RheumMadness leadership team discusses our approach to RheumMadness bracketology, including our favorites, dark horses, and read on the Blue Ribbon Panel. Submit your brackets by March 31, 2025 at 11:59pm ET! To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.or

  • Mar 12, 2025 · 54 min

    5.11 More Panelists Plus CAR-Ts in NephMadness

    In this episode, we introduce the rest of the Blue Ribbon Panel and interview our friends from NephMadness about their CAR-T region. Remember, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Blue Ribbon Panelists in this episode: Anastasiya (Stacy) Bagrova, MD completed internal medicine residency at Duke, rheumatology fellowship at the University of South Florida, and is now a practicing rheumatologist in Clearwater, FL. Similar to her clinical practice, her clinical interests in rheumatology are broad. Follow her on X at @asbagrova. Eric Dein, MD, is currently living in Jersey City, NJ – hometown of the March Madness great Cinderella St Peter’s Peacock team. He is currently practicing rheumatology at Atlantic Health System at Overlook Hospital in Summit and West Orange, NJ, after completing medical school, residency and fellowship at Johns Hopkins. He is a USSONAR alumnus who utilizes musculoskeletal ultrasound in diagnosis and management of rheumatic disease. He is currently serving as ACR committee member on the Annual Meeting Planning Committee and enjoys advocacy trips to DC with Advocates for Arthritis. He has been a reporter for RheumNow at rheumatology conferences for the past 5 years. Follow him on X at @ericdeinmd. Rebecca Grainger, MB ChB (Dstn), PhD, FRACP, is Professor of Medicine at the University of Otago, Wellington, New Zealand. A University of Otago medical graduate, she undertook rheumatology training in Melbourne and her PhD examined inflammatory mechanisms in gout. Dr. Grainger’s clinical work focuses on assessment and management of inflammatory arthritis and her particular clinical interests include inflammatory arthritis, gout, and scleroderma. Dr. Grainger’s academic interests are wide but she aims to undertake research in clinical rheumatology, health professions education and technology. Follow her on X @Drbeckyg and on Bluesky at @profbeckyg.bsky.social. Lakshmi Jayaram, MD, is a clinician educator and Assistant Professor in the Division of Immunology and Rheumatology at Stanford University. Her academic interests are mainly in medical education, quality improvement, patient safety and social determinants of health. As a clinician, she is a general rheumatologist with special interests in myositis, gout, psoriatic arthritis, and vasculitis. Molly Leavitt, MD, MBA, is a first-year rheumatology fellow at the University of South Florida. Her interests include medical education and reproductive health for patients with rheumatic diseases. To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.or

  • Mar 5, 2025 · 33 min

    5.10 The Blue Ribbon Panel

    In this episode, we introduce 2 of our fantastic Blue Ribbon Panel members. Their full bios are listed below. You'll meet the rest of the panel in the next episode! Also, RheumMadness brackets are open through March 31 at 11:59pm ET! Submit your brackets here. First time playing RheumMadness? Check out our new explainer video! Panelists in this podcast: Michele Meltzer, MD, MBE, is an Associate Professor of Medicine at Thomas Jefferson University in Philadelphia, Pennsylvania. She attended Hahnemann Medical School and rheumatology fellowship at Temple University Hospital. In 2007, she completed a Master’s of Bioethics at the University of Pennsylvania. Dr. Meltzer has been a ACR committee member of Rheumatologic Care and Ethics and Conflict of Interest committees. She serves as President and founding member of Rheumatology for All, a nonprofit whose mission is to increase access to rheumatology care in resource limited areas. She loves that RheumMadness makes learning about rheumatology fun and is accessible to students worldwide. Lisa Traboco, MD, is a rheumatologist with a passion for digital health, social media, telemedicine, and medical education. She likes to integrate technology into clinical practice and training, as well as participate in systems implementation. She is currently pursuing a Master’s in Health Informatics while working at St. Luke’s Medical Center – Global City in the Philippines. She is also actively involved in APLAR & has been an exchange scholar to Japan and the ACR. Her interests include learning languages, watching K-dramas & visiting historical museums. Follow her on X at @rheumarhyme and Bluesky at @rheumarhyme.bsky.social. To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Feb 26, 2025 · 29 min

    5.9 B-Cell Breakaway Part 2

    In this episode we are joined by some amazing collaborators from the EMEUNET to talk about the STRAP trials. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship Program STRAP trial, by the Emerging EULAR Network (EMEUNET) Links to theMednet.org Q&As about this region: In the treatment of lupus nephritis, which patients may benefit from the use of rituximab or other B-cell depleting agents during induction? What are the potential barriers to the widespread use of obinutuzumab in proliferative lupus nephritis? How do you envision incorporating CAR-T therapy into your clinical practice? Does synovial biopsy provide diagnostic value in undifferentiated inflammatory arthritis? To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Feb 19, 2025 · 48 min

    5.8 B-Cell Breakaway

    In this episode we discuss obinutuzumab for lupus nephritis and anti-CD19 CAR T Cell therapy for autoimmune rheumatic disease. Links to the B-Cell Breakaway Scouting Reports: Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship Program STRAP trial, by the Emerging EULAR Network (EMEUNET) Links to theMednet.org Q&As about this region: In the treatment of lupus nephritis, which patients may benefit from the use of rituximab or other B-cell depleting agents during induction? What are the potential barriers to the widespread use of obinutuzumab in proliferative lupus nephritis? How do you envision incorporating CAR-T therapy into your clinical practice? Does synovial biopsy provide diagnostic value in undifferentiated inflammatory arthritis? To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Feb 12, 2025 · 17 min

    5.7 Full Court Care Champions Part 2

    In this episode we present part 2 of our conversation about the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency Program Steroid dose in lupus nephritis, by the Washington University in St. Louis (WUSTL) Adult Rheumatology Fellowship Program SGCAPS prediction tool, by the Medical College of Wisconsin Adult Rheumatology Fellowship Program. Links to theMednet.org Q&As about this region: How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness? What steroid regimen do you typically use for induction therapy in patients with lupus nephritis? How do you make the decision to empirically treat for GCA when a patient is referred but cannot be immediately seen in clinic? To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Feb 5, 2025 · 31 min

    5.6 Full Court Care Champions

    In this episode we dive into the teams in the Full Court Care Champions region of RheumMadness 2025! Links to the Full Court Care Champions Scouting Reports: Cost-effectiveness of hydroxychloroquine retinopathy screening, by residents from the Lankenau Medical Center Internal Medicine Residency Program Steroid dose in lupus nephritis, by the Washington University in St. Louis (WUSTL) Adult Rheumatology Fellowship Program SGCAPS prediction tool, by the Medical College of Wisconsin Adult Rheumatology Fellowship Program. Links to theMednet.org Q&As about this region: How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness? What steroid regimen do you typically use for induction therapy in patients with lupus nephritis? How do you make the decision to empirically treat for GCA when a patient is referred but cannot be immediately seen in clinic? To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Jan 29, 2025 · 29 min

    5.5 Cytokine Crushers Part 2

    This episode contains part 2 of our conversation with Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, about the Cytokine Crushers region of RheumMadness 2025. In this episode, we focus specifically on the TYK2 in SLE and Oral Anti-IL23 teams. Links to the Cytokine Crushers Scouting Reports: Oral anti-IL23, by collaborating Chicago area rheumatology fellowship programs (Loyola, Northwestern, and the University of Chicago) Long-term outcomes of anifrolumab in SLE, by the Medical University of South Carolina (MUSC) Adult Rheumatology Fellowship TYK2 inhibitor in SLE, by the University of North Carolina (UNC) Adult Rheumatology Fellowship Links to theMednet.org Q&As about this region: What circumstances would drive you to consider using an oral IL-23 inhibitor over parenteral options for management of psoriasis/PsA? How will you utilize newly FDA approved anifrolumab for SLE in your practice? What is your experience with using oral deucravicitinib for conditions such as recalcitrant facial discoid lupus or recalcitrant lichen planus? To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Jan 22, 2025 · 36 min

    5.4 Cytokine Crushers

    In this episode, we are joined by Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, to discuss the teams in the Cytokine Crushers region of RheumMadness 2025, the Innovation Invitational. This is part 1 of the conversation, where we go in depth about the long-term outcomes of anifrolumab in SLE study and give a primer about type 1/2 cytokines so you're ready to dig into the TYK2 in SLE and Oral Anti-IL23 studies. Join us again next week for part 2 of this discussion to learn more about this region. Links to the Cytokine Crushers Scouting Reports: Oral anti-IL23, by collaborating Chicago area rheumatology fellowship programs (Loyola, Northwestern, and the University of Chicago) Long-term outcomes of anifrolumab in SLE, by the Medical University of South Carolina (MUSC) Adult Rheumatology Fellowship TYK2 inhibitor in SLE, by the University of North Carolina (UNC) Adult Rheumatology Fellowship Links to old scouting reports and other studies referenced in this podcast: TULIP 1/2 scouting report from RheumMadness 2021 LLDAS scouting report from RheumMadness 2024 Morand EF, Abreu G, Furie RA, Golder V, Tummala R. Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus. Ann Rheum Dis. 2023 May;82(5):639-645. doi: 10.1136/ard-2022-222748. Epub 2023 Jan 23. Erratum in: Ann Rheum Dis. 2024 Apr 11;83(5):e12. doi: 10.1136/ard-2022-222748corr1. PMID: 36690388; PMCID: PMC10176410. Tanaka Y. Viewpoint on anifrolumab in patients with systemic lupus erythematosus and a high unmet need in clinical practice. RMD Open. 2023 Aug;9(3):e003270. doi: 10.1136/rmdopen-2023-003270. Erratum in: RMD Open. 2024 Apr 4;10(2):e003270corr1. doi: 10.1136/rmdopen-2023-003270corr1. PMID: 37597847; PMCID: PMC10441065. ORAL Surveillance scouting report from RheumMadness 2024 To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Jan 15, 2025 · 1 hr 2 min

    5.3 T'd Up T-Cells Part 2

    In this episode, we present the second part of our conversation with the authors of the scouting reports for the teams in the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational. Plus, we highlight Q&As from theMednet.org about the T'd Up T-Cells teams AND record an interview with Dr. Bill St. Clair, the first author of the phase 2 dazodalibep study. It's a long episode because there's so much content! Links to the Q&As from theMednet.org discussed in this episode: What is your approach to managing sicca symptoms in patients not responding or not tolerating conservative measures, pilocarpine, and cevimeline? What is your approach to immunomodulatory treatment in patients with Sjogren’s syndrome who have active serologies (i.e. elevated ESR, hypergammaglobulinemia, hypocomplementemia) but minimal symptoms? What is your approach to monitoring patients referred for high titer +RF and +CCP but without active symptoms of inflammatory arthritis? What factors drive you to prioritize T vs B cell inhibition when choosing therapies for patients with refractory SLE? To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Jan 8, 2025 · 36 min

    5.2 T'd Up T-Cells

    In this episode, we dive in to the T'd Up T-cells region of RheumMadness 2025: the Innovation Invitational. This is the first of a two-part conversation with the authors of the scouting reports for the teams in this region. Check back next week to hear the rest of the conversation! To find the scouting reports and base articles discussed in this episode, head over to the scouting reports page of our website here: https://sites.duke.edu/rheummadness/bracket-and-scouting-reports/ To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Jan 8, 2025 · 5 min

    5.1 Welcome Back!

    Welcome back to RheumMadness, the place for everyone who is crazy about rheumatology to connect, collaborate, compete, and learn together. The podcast took a hiatus in 2024 (hence why there are no episodes labeled season 4), but we we are thrilled to announce that the podcast is back for 2025 and beyond. In this episode, we explain some changes to the RheumMadness format and get you ready to experience everything this season has to offer. Find out more on the RheumMadness website: https://sites.duke.edu/rheummadness/ Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/rheummadness/ X: Follow #RheumMadness Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Apr 5, 2023 · 38 min

    3.8 Final Recap and Thank You

    In this episode, we are joined by two Blue Ribbon Panel members (Dr. Julie Paik and Dr. Angus Worthing) to recap the results of RheumMadness 2023. Plus, we hear from Dr. Nina Couette to review all the RheumMadness-related content on theMednet.org. Find out more on the RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Mar 15, 2023 · 36 min

    3.7 Who's Your Champion?

    For this episode, we invited anyone who wanted to join us for a live group discussion about the All Star Season. The result? Our first international guest on the podcast, two more fellow scouting report authors, and a ton of fun. Plus, hear Guy Katz make his picks (so you know who not to pick in the tournament), and hear a rundown of what we think the Blue Ribbon Panel might do. RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Mar 4, 2023 · 28 min

    3.6 Bracketology - Right Side (Part 2)

    In this episode, we discuss the right side of the bracket for RheumMadness 2023 with the scouting report authors. (Part 2 of 2) RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Mar 4, 2023 · 17 min

    3.5 Bracketology - Right Side (Part 1)

    In this episode, we discuss the right side of the bracket for RheumMadness 2023 with the scouting report authors. (Part 1 of 2) RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/

  • Feb 25, 2023 · 16 min

    3.4 Bracketology - Left Side (Part 2)

    In this episode, we discuss the left side of the bracket for RheumMadness 2023 with the scouting report authors. (Part 2 of 2) RheumMadness website: https://sites.duke.edu/rheummadness/ Intro/outro music: Cheery Monday by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3495-cheery-monday License: http://creativecommons.org/licenses/by/4.0/